Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

AMERICAN CONTRACT SYSTEMS, INC.

US

Last updated May 23, 2026

What AMERICAN CONTRACT SYSTEMS, INC. makes

American Contract Systems, Inc. manufactures single-use, non-medicated general surgical procedure kits designed for various surgical applications. These kits are intended for one-time use in operating room settings and include essential tools and instruments required for specific surgical procedures.

The company’s products are regulated under FDA classification as either Class I or Class II devices, with some falling under the non-classifiable (N) category. These devices are listed in the FDA’s Unique Device Identifier (UDI) database, ensuring traceability and compliance with U.S. regulatory requirements.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
010334675

Catalogue (21894)

Page 22 of 438
DeviceModel / ReferenceRegistriesClassStatus
Acs HENE13AB
FDA UDI
Class IIActive
Acs JSSA18A
FDA UDI
Class IIActive
Acs CECY88O
FDA UDI
Class IIActive
Acs CCHG48A
FDA UDI
Class IActive
Acs HZOB40A
FDA UDI
Class IIActive
Acs AHPO55H
FDA UDI
Class IIActive
Acs HGXR41D
FDA UDI
Class IIActive
Acs HSSS70F
FDA UDI
Class IIActive
Acs SASA18G
FDA UDI
Class IActive
Acs MTPL14A
FDA UDI
Class IActive
Acs BFHY75Z
FDA UDI
Class IIActive
Acs PCLT44F
FDA UDI
Class IIActive
Acs LMSN44S
FDA UDI
Class IActive
Acs MEPE03P
FDA UDI
Class IIActive
Acs FHEN02P
FDA UDI
Class IIActive
Acs HHCC56D
FDA UDI
Class IIActive
Acs LMPL56G
FDA UDI
Class IIActive
Acs LSRCFTOKNEC
FDA UDI
Class IActive
Acs SJCP39C
FDA UDI
Class IIActive
Acs OGCL30E
FDA UDI
Class IIActive
Acs AGRO47L
FDA UDI
Class IIActive
Acs SAAC27F
FDA UDI
Class IIActive
Acs UIVS88S
FDA UDI
Class IIActive
Acs FHCP08N
FDA UDI
Class IIActive
Acs AHAR50D
FDA UDI
Class IIActive
Acs SMGP33L
FDA UDI
Class IIActive
Acs SLNK35A
FDA UDI
Class IIActive
Acs CXBS22E
FDA UDI
Class IIActive
Acs CEAT19H
FDA UDI
Class IIActive
Acs FDCL22M
FDA UDI
Class IIActive
Acs UIGN80M
FDA UDI
Class IIActive
Acs UDVK77T
FDA UDI
Class IIActive
Acs UDVK77V
FDA UDI
Class IIActive
Acs PCDC52B
FDA UDI
NActive
Acs MYLO12E
FDA UDI
Class IIActive
Acs UICD62AD
FDA UDI
Class IIActive
Acs FBOH98P
FDA UDI
Class IIActive
Acs PWTS78N
FDA UDI
Class IIActive
Acs CDOB98F
FDA UDI
Class IIActive
Acs GSMO00G
FDA UDI
Class IIActive
Acs ICLC46F
FDA UDI
Class IIActive
Acs ANLP25AC
FDA UDI
Class IIActive
Acs MEAN19O
FDA UDI
Class IIActive
Acs HSVH80I
FDA UDI
Class IIActive
Acs COTH47N
FDA UDI
Class IActive
Acs UISK00A
FDA UDI
Class IIActive
Acs MTAN13C
FDA UDI
Class IIActive
Acs SFMB05C
FDA UDI
Class IIActive
Acs LSRSMHPORTA
FDA UDI
Class IIActive
Acs JEUE72B
FDA UDI
Class IActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (100)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

American Contract Systems, Inc. has 190 recall records spanning from December 28, 2016, to March 19, 2026, with statuses recorded as open, classified, or terminated. The reasons cited include concerns about incomplete sterilization, improper handling of components during sterilization processes, incorrect expiration dates, labeling errors, insufficient aeration time, and deviations from sterilization specifications. Some recalls involved third-party products or components, such as syringes from Medline Industries, and the use of FDA-banned substances in powdered surgical gloves.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Mar 19, 2026Z-1981-2026—open, classified

Impacted kits contain syringes recalled by Medline Industries. Syringe rotating adaptor may unwind during use, which may result in a loose connection or full disconnection between the syringe and manifold. Potential risk for biohazard exposure, blood loss, infection, or air embolism.

Sep 4, 2025Z-0179-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0185-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0187-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0180-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0178-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0172-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0171-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0183-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0174-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0175-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0177-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0186-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0173-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0170-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0184-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0181-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0182-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Sep 4, 2025Z-0176-2026—open, classified

Identified products were re-gassed (sterilized more than once) after a nonconformance occurred during the initial Ethylene Oxide (EO) gas injection process. These products have not been validated for exposure to multiple sterilization cycles. Therefore, product quality, safety, and effectiveness cannot be confirmed for product that was re-gassed.

Jul 14, 2025Z-2466-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2471-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2465-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2467-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2468-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2469-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2470-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2464-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Jul 14, 2025Z-2472-2025—open, classified

During an internal investigation, ACS determined that the rationale for sterilization of certain components was not justified and therefore, some components are not fit for further sterilization according to ACS procedures. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Apr 21, 2025Z-1916-2025—open, classified

Test results for cast padding component included in procedure trays shows Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals exceeded residual limits, which may lead to a possible loss or lack of functionality that may lead to a delay or prolonged treatment/procedure/therapy.

Feb 6, 2025Z-1332-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1333-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1349-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1345-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1359-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1356-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1339-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1348-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1358-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1361-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1346-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1331-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1350-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1355-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1347-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1353-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1362-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1354-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1341-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1338-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1352-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1342-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1334-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1357-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1360-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1340-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1335-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1336-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1344-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1337-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1343-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 6, 2025Z-1351-2025—open, classified

ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.

Feb 4, 2025Z-1406-2025—open, classified

During an internal investigation, ACS was unable to confirm that the CODMAN component achieved the required Sterility Assurance Level and therefore is not suitable for sterilization according to ACS procedures.

Jan 31, 2025Z-1425-2025—open, classified

Sterility assurance with procedure trays

Jan 31, 2025Z-1426-2025—open, classified

Sterility assurance with procedure trays

Jan 31, 2025Z-1424-2025—open, classified

Sterility assurance with procedure trays

Aug 7, 2024Z-3230-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3238-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3239-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3227-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3241-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3233-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3242-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3226-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3231-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3229-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3237-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3244-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3232-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3228-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3235-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3240-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3236-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3243-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

Aug 7, 2024Z-3234-2024—open, classified

ACS identified that due to an inoperable chart recorder, humidity readings were out-of-specification in one of the controlled environment areas. As a result, ACS is unable to confirm product sterilization assurance requirements were met.

May 15, 2024Z-2274-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2277-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2304-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2283-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2310-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2290-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2284-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2275-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2301-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2299-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2280-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2281-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2307-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2306-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2303-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.

May 15, 2024Z-2308-2024—open, classified

Ethylene Oxide/Ethylene Chlorohydrin (EO/ECH) residuals for the cast padding component exceeded the residual limits for permanent exposure devices as indicated by ANSI/AAMI/ISO 10993-7/(R)2012.